Cite
MLA Citation
Jonathan Pan et al.. “Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.” Leukemia & lymphoma, vol. 62, no. 3, 2021, pp. 590–597. http://access.bl.uk/ark:/81055/vdc_100124342014.0x000033